These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206 [TBL] [Abstract][Full Text] [Related]
11. Mixed cytokine profile during active cutaneous leishmaniasis and in natural resistance. Baratta-Masini A; Teixeira-Carvalho A; Malaquias LC; Mayrink W; Martins-Filho OA; Corrêa-Oliveira R Front Biosci; 2007 Jan; 12():839-49. PubMed ID: 17127341 [TBL] [Abstract][Full Text] [Related]
12. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861 [TBL] [Abstract][Full Text] [Related]
13. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975 [TBL] [Abstract][Full Text] [Related]
14. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Bomfim G; Nascimento C; Costa J; Carvalho EM; Barral-Netto M; Barral A Exp Parasitol; 1996 Nov; 84(2):188-94. PubMed ID: 8932768 [TBL] [Abstract][Full Text] [Related]
15. Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Skeiky YA; Benson DR; Guderian JA; Whittle JA; Bacelar O; Carvalho EM; Reed SG Infect Immun; 1995 Oct; 63(10):4105-14. PubMed ID: 7558326 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response. Brachelente C; Müller N; Doherr MG; Sattler U; Welle M Vet Pathol; 2005 Mar; 42(2):166-75. PubMed ID: 15753470 [TBL] [Abstract][Full Text] [Related]
18. Regulator and effector functions of T-cell subsets in human Leishmania infections. Kemp M APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493 [TBL] [Abstract][Full Text] [Related]
19. Cloning and sequence analysis of Peromyscus yucatanicus (Rodentia) Th1 (IL-12p35, IFN-γ and TNF) and Th2 (IL-4, IL-10 and TGF-β) cytokines. Loria-Cervera EN; Sosa-Bibiano EI; Villanueva-Lizama LE; Van Wynsberghe NR; Schountz T; Andrade-Narvaez FJ Cytokine; 2014 Jan; 65(1):48-55. PubMed ID: 24120849 [TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12. Bourreau E; Prévot G; Pradinaud R; Launois P J Infect Dis; 2001 Mar; 183(6):953-9. PubMed ID: 11237813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]